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procedure at those institutions with maybe worse results. So when
you suggest that things are safe, that’s why I say it is safe at your
institution, but maybe not necessarily at others. Now having said
all this, my bias is toward early conversion to the cavopulmonary
shunt, and as more institutions move toward earlier and earlier
conversion, the question of how young is too young, I am certain,
will be answered.
Dr Winfield Wells (Los Angeles, Calif). Just 1 short question.
I am wondering if any of the patients received nitric oxide after
their bidirectional Glenn.
Dr Jaquiss. I don’t have that in the manuscript. I don’t have the
data, but I can recall anecdotally 1. The child who had the pul-
monary artery thrombosis who was a very young patient was
incredibly hypoxemic 2 days postoperatively, and among the many
things that were done as that child was taken down for angiogra-
phy was the addition of nitric oxide, which had absolutely no
benefit.
Dr Wells. Okay, but no other patients.
Dr Jaquiss. Not that I can recall.
Dr Wells. And just finally, summarizing a little bit of what has
been said, would you now be willing to restate some of the final
conclusions, that is to say, that you have proven that this is safe in
your institution but you have no evidence that it is beneficial.
Dr Jaquiss. Yes, I think that’s fair.
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